![]() Skyhawk Therapeutics Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression. | ![]() CAMP4 Therapeutics CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression. | Standigm Standigm is a workflow artificial intelligence (AI) drug discovery company that generates therapeutic lead compounds. | ![]() MBX Biosciences MBX Biosciences is a clinical-stage biopharmaceutical company that develops novel precision peptide therapies for endocrine and metabolic disorders. | |
Founding Date | Founding Date 2016 | Founding Date 2016 | Founding Date 2015 | Founding Date 2018 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Waltham, US HQ Basel, CH | Locations Cambridge, US HQ | Locations KR HQ Cambridge, GB Cambridge, US | Locations Carmel, US HQ |
Employees | Employees 673% decrease | Employees 66 | Employees 297% increase | Employees 36 |
Financial | ||||
Net income | Net income N/A | Net income ($80.4m) (FY, 2025) | Net income N/A | Net income ($87m) (FY, 2025) |
Funding | ||||
Latest funding round | Latest funding round $ 40m (about 8 years ago) | Latest funding round N/A | Latest funding round $ 10m (about 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 48m | Total funding raised $ 30m | Total funding raised $ 69.7m | Total funding raised $ 34.6m |

CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression.
View companyStandigm is a workflow artificial intelligence (AI) drug discovery company that generates therapeutic lead compounds.
View company
MBX Biosciences is a clinical-stage biopharmaceutical company that develops novel precision peptide therapies for endocrine and metabolic disorders.
View company